Ixazomib enhances the antitumor effect of brigatinib in TP53-mutated EML4-ALK lung cancer cells. // International Journal of Lung Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X26000483?dgcid=rss_sd_all
Ixazomib enhances the antitumor effect of brigatinib in TP53-mutated EML4-ALK lung cancer cells. International Journal of Lung Cancer. https://www.sciencedirect.com/science/article/pii/S3117504X26000483?dgcid=rss_sd_all
“Ixazomib enhances the antitumor effect of brigatinib in TP53-mutated EML4-ALK lung cancer cells.” International Journal of Lung Cancer.
@article{article94070,
title = {Ixazomib enhances the antitumor effect of brigatinib in TP53-mutated EML4-ALK lung cancer cells},
journal = {International Journal of Lung Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X26000483?dgcid=rss_sd_all}
}